Literature DB >> 12432213

Repaglinide: a short acting insulin secretagogue for postprandial hyperglycaemia.

V Ambavane1, R Patil, S S Ainapure.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12432213

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN： 0022-3859            Impact factor:   1.476


× No keyword cloud information.
  2 in total

1.  The pregnane X receptor agonist St John's Wort has no effects on the pharmacokinetics and pharmacodynamics of repaglinide.

Authors:  Lan Fan; Gan Zhou; Dong Guo; Ya-Li Liu; Wang-Qing Chen; Zhao-Qian Liu; Zhi-Rong Tan; Deng Sheng; Hong-Hao Zhou; Wei Zhang
Journal:  Clin Pharmacokinet       Date:  2011-09       Impact factor: 6.447

2.  Kir6.2-dependent high-affinity repaglinide binding to beta-cell K(ATP) channels.

Authors:  Ann Maria K Hansen; John Bondo Hansen; Richard D Carr; Frances M Ashcroft; Philip Wahl
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.